Literature DB >> 1377112

Cyclosporin for Crohn's disease?

M Guslandi1, A Tittobello.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1377112     DOI： 10.2165/00003495-199243040-00002

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  16 in total

1.  Final report on a placebo-controlled, double-blind, randomized, multicentre trial of cyclosporin treatment in active chronic Crohn's disease.

Authors:  J Brynskov; L Freund; S Nørby Rasmussen; K Lauritsen; O Schaffalitzky de Muckadell; C N Williams; A S MacDonald; R Tanton; F Molina; M C Campanini
Journal:  Scand J Gastroenterol       Date:  1991-07       Impact factor: 2.423

2.  Cyclosporine in Crohn's disease.

Authors: 
Journal:  N Engl J Med       Date:  1990-03-01       Impact factor: 91.245

3.  Renographic monitoring of renal function in patients with Crohn's disease treated with low dose cyclosporin: a controlled study.

Authors:  J Brynskov; H Thomsen; S L Nielsen
Journal:  BMJ       Date:  1990-06-02

4.  Health care issues in presidential campaigns.

Authors:  V Navarro
Journal:  N Engl J Med       Date:  1990-03-01       Impact factor: 91.245

5.  Cyclosporin: use outside transplantation.

Authors:  A W Thomson; G H Neild
Journal:  BMJ       Date:  1991-01-05

6.  Unsatisfactory effect of cyclosporin A treatment in Crohn's disease: a report of five cases.

Authors:  R Löfberg; B Angelin; K Einarsson; N Gabrielsson; L Ost
Journal:  J Intern Med       Date:  1989-09       Impact factor: 8.989

7.  Treatment of Crohn's disease in relapse with cyclosporin A.

Authors:  N R Parrott; R M Taylor; C W Venables; C O Record
Journal:  Br J Surg       Date:  1988-12       Impact factor: 6.939

8.  Mechanism of cyclosporin A-induced immunosuppression. Cyclosporin A inhibits receptor-mediated and non-receptor-mediated lymphokine production as well as interleukin-2-induced proliferation in cloned T lymphocytes.

Authors:  D T Harris; W J Kozumbo; P A Cerutti; J C Cerottini
Journal:  Cell Immunol       Date:  1987-10-01       Impact factor: 4.868

9.  Effect of the immune modulating agents cyclophosphamide, methotrexate, hydrocortisone, and cyclosporin A on an animal model of granulomatous bowel disease.

Authors:  I C Mitchell; J L Turk
Journal:  Gut       Date:  1990-06       Impact factor: 23.059

10.  Cyclosporin for Crohn's disease.

Authors:  M C Allison; R E Pounder
Journal:  Aliment Pharmacol Ther       Date:  1987-02       Impact factor: 8.171
View more
  2 in total

Review 1.  Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

Authors:  Diana Faulds; Karen L Goa; Paul Benfield
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

Review 2.  Immunomodulator therapy in inflammatory bowel disease.

Authors:  P M Choi; S R Targan
Journal:  Dig Dis Sci       Date:  1994-09       Impact factor: 3.199
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.